Business ResMed earnings results: Clear Beat of $0.24 EPS Expectations Russell ClarksonNovember 2, 20260 ResMed earnings results show a clear beat of $0.24 EPS expectations, highlighting the company’s strong performance.
Business GM buyback approval: Is it the best financial move? Russell ClarksonOctober 20, 20260 GM buyback approval brings optimism after Q3 2026 earnings beat expectations.